Gritstone bio, Inc. (GRTS) — Analyst outlook / Analyst consensus target is. Based on 13 analyst ratings, the consensus is bullish — 7 Buy, 4 Hold, 2 Sell.
The consensus price target is $4.67 (low: $3.00, high: $6.00), representing an upside of 14403.1% from the current price $0.03.
GRTS Stock — 12-Month Price Forecast
$4.67
▲ +14,403.11% Upside
Average Price Target
Based on 13 Wall Street analysts offering 12-month price targets for Gritstone bio, Inc., the average price target is $4.67, with a high forecast of $6.00, and a low forecast of $3.00.
The average price target represents a +14,403.11% change from the last price of $0.03.
Highest Price Target
$6.00
Average Price Target
$4.67
Lowest Price Target
$3.00
GRTS Analyst Ratings
Buy
Based on 13 analysts giving stock ratings to Gritstone bio, Inc. in the past 3 months
